These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 27714756)

  • 21. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular pharmacogenomics: current status and future directions.
    Roden DM
    J Hum Genet; 2016 Jan; 61(1):79-85. PubMed ID: 26178435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Translating Genomic Advances to Physical Therapist Practice: A Closer Look at the Nature and Nurture of Common Diseases.
    Curtis CL; Goldberg A; Kleim JA; Wolf SL
    Phys Ther; 2016 Apr; 96(4):570-80. PubMed ID: 26637647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation.
    Ong FS; Deignan JL; Kuo JZ; Bernstein KE; Rotter JI; Grody WW; Das K
    Pharmacogenomics; 2012 Mar; 13(4):465-75. PubMed ID: 22380001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art.
    Ross S; Krebs K; Paré G; Milani L
    Stroke; 2023 Jan; 54(1):270-278. PubMed ID: 36325912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
    Carrillo Norte JA
    Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring predisposition and treatment response--the promise of genomics.
    Pan S; Knowles JW
    Prog Cardiovasc Dis; 2012; 55(1):56-63. PubMed ID: 22824110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics in Oral Antithrombotic Therapy.
    Maier CL; Duncan A; Hill CE
    Clin Lab Med; 2016 Sep; 36(3):461-72. PubMed ID: 27514462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke genetics: prospects for personalized medicine.
    Markus HS
    BMC Med; 2012 Sep; 10():113. PubMed ID: 23016624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic signatures in the treatment of stroke.
    Munshi A; Sharma V
    Curr Pharm Des; 2015; 21(3):343-54. PubMed ID: 25163728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
    Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular pharmacogenomics and individualized drug therapy.
    Pereira NL; Weinshilboum RM
    Nat Rev Cardiol; 2009 Oct; 6(10):632-8. PubMed ID: 19707183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics and genomics: the scientific drivers of personalized medicine.
    Kurnat-Thoma EL
    Annu Rev Nurs Res; 2011; 29():27-54. PubMed ID: 22891497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.
    Krasi G; Precone V; Paolacci S; Stuppia L; Nodari S; Romeo F; Perrone M; Bushati V; Dautaj A; Bertelli M
    Acta Biomed; 2019 Sep; 90(10-S):7-19. PubMed ID: 31577248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).
    O'connor CT; Kiernan TJ; Yan BP
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):725-739. PubMed ID: 28571507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized cardiovascular medicine: status in 2012.
    Dandona S; Roberts R
    Can J Cardiol; 2012; 28(6):693-9. PubMed ID: 23036280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics.
    Raoufinia R; Rahimi HR; Abbaszadeh M; Gholoobi A; Saburi E; Fakoor F; Alshakarchi HI; Gataa IS; Hassanian SM; Ferns GA; Khazaei M; Avan A
    Curr Pharm Des; 2024; 30(21):1667-1680. PubMed ID: 38738725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for personalized cardiovascular medicine: the impact of genomics.
    Ginsburg GS; Donahue MP; Newby LK
    J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.